PDB64 COST-EFFECTIVENESS OF CANAGLIFLOZIN TREATMENT IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.946
https://www.valueinhealthjournal.com/article/S1098-3015(19)33324-8/fulltext
Title :
PDB64 COST-EFFECTIVENESS OF CANAGLIFLOZIN TREATMENT IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33324-8&doi=10.1016/j.jval.2019.09.946
First page :
Section Title :
Open access? :
No
Section Order :
10838